Use of N-desmethylclozapine to treat human neuropsychiatric disease

Details for Australian Patent Application No. 2004206931 (hide)

Owner Acadia Pharmaceuticals Inc

Inventors Weiner, David M.; Brann, Mark R.

Agent Griffith Hack

Pub. Number AU-A-2004206931

PCT Pub. Number WO2004/064753

Priority 60/442,690 23.01.03 US

Filing date 21 January 2004

Wipo publication date 5 August 2004

International Classifications

A61K 031/551 - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

Event Publications

21 July 2005 PCT application entered the National Phase

  PCT publication WO2004/064753 Priority application(s): WO2004/064753

19 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004206939-Cultured pearl nuclei and method of fabricating same from calciumcarbonate precursor powders

2004206921-Catheter design that facilitates positioning at tissue to be diagnosed or treated